Orthopediatrics (KIDS) Getting Somewhat Favorable Press Coverage, Analysis Shows

News stories about Orthopediatrics (NASDAQ:KIDS) have trended somewhat positive on Sunday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Orthopediatrics earned a coverage optimism score of 0.02 on Accern’s scale. Accern also gave press coverage about the company an impact score of 46.7138834460832 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Several equities analysts have recently weighed in on KIDS shares. Piper Jaffray Companies assumed coverage on Orthopediatrics in a report on Monday, November 6th. They issued an “overweight” rating and a $24.00 price objective for the company. William Blair assumed coverage on Orthopediatrics in a report on Monday, November 6th. They set an “outperform” rating for the company. Stifel Nicolaus assumed coverage on Orthopediatrics in a report on Monday, November 6th. They set a “buy” rating and a $23.00 price target for the company. Zacks Investment Research cut Orthopediatrics from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Finally, BidaskClub cut Orthopediatrics from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating and four have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $23.67.

Orthopediatrics (NASDAQ KIDS) traded up $0.09 during trading on Friday, reaching $18.71. The company had a trading volume of 77,236 shares, compared to its average volume of 30,684. Orthopediatrics has a fifty-two week low of $17.03 and a fifty-two week high of $23.00. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00.

Orthopediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Wednesday, November 8th. The company reported ($1.70) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($1.58). sell-side analysts predict that Orthopediatrics will post -1.41 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Week Herald and is owned by of Week Herald. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://weekherald.com/2018/01/21/orthopediatrics-kids-getting-somewhat-favorable-press-coverage-analysis-shows.html.

Orthopediatrics Company Profile

OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Insider Buying and Selling by Quarter for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply